EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

DeepADR: multimodal prediction of adverse drug reaction frequency by integrating early-stage drug discovery information via Kolmogorov–Arnold networks

Jingting Wan, Chenyang Jia, Danhong Dong, Yigang Chen, Yang-Chi-Dung Lin, Yisheng He, Hsi-Yuan Huang iD, Hsien-Da Huang iD

Briefings in Bioinformatics · 2025

DOI: 10.1093/bib/bbaf695 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Briefings in Bioinformatics, 2025. Verfasst von Jingting Wan und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, The Chinese University of Hong Kong, Shenzhen, No. 2001 Longxiang Road, Longgang District, Shenzhen, Guangdong 518172, P.R. China. Hauptthemen laut MEDLINE: Drug-Related Side Effects and Adverse Reactions, Drug Discovery, Deep Learning. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Guangdong Young Scholar Development Fund of Shenzhen Ganghong Group Co., Ltd., Shenzhen-Hong Kong Cooperation Zone for Technology and Innovation, Warshel Institute for Computational Biology funding from Shenzhen City and Longgang District.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Adverse drug reactions (ADRs) are a major cause of clinical trial failure and postmarket withdrawal, posing significant risks to public health and impeding drug development. While computational methods offer an alternative to costly preclinical testing, existing models often fail with novel compounds by requiring pre-existing information such as drug-ADR associations or by inadequately integrating diverse data sources. Here, we introduce DeepADR, a multimodal deep learning framework for predicting both the occurrence and frequency of ADRs using early-stage, readily available data. DeepADR integrates chemical structures and biological target profiles with semantic representations of ADR terms derived from a large language model (LLMs). These heterogeneous parameters are fused using a Kolmogorov–Arnold Network (KAN), which enhances the modeling of complex, nonlinear relationships among modalities to improve predictive performance. Our model outperforms existing methods in predicting both ADR occurrence and frequency, demonstrating robust generalization to new chemical entities. DeepADR showed consistently better performance than other models across both classification and regression tasks. By effectively integrating chemical, biological, and semantic datasets, DeepADR provides a powerful, scalable tool for the early-stage safety assessment and candidate prioritization. This framework not only facilitates the prioritization of safer drug candidates but also offers a methodology for predicting the toxicity of other hazardous materials, holding significant promise for advancing public health.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug-Related Side Effects and Adverse ReactionsDrug DiscoveryDeep LearningHumansComputational Biology

Stichwörter der Autor:innen

Kolmogorov–Arnold networkadverse drug reactionsdrug developmentmolecular representationmulti modal deep learning

Autor:innen und Institutionen

  • School of Medicine, The Chinese University of Hong Kong, Shenzhen, No. 2001 Longxiang Road, Longgang District, Shenzhen, Guangdong 518172, P.R. China.
  • Warshel Institute for Computational Biology, School of Medicine, The Chinese University of Hong Kong, Shenzhen, No. 2001 Longxiang Road, Longgang District, Shenzhen, Guangdong 518172, P.R. China.
  • Guangdong Provincial Key Laboratory of Digital Biology and Drug Development, The Chinese University of Hong Kong, Shenzhen, No. 2001 Longxiang Road, Longgang District, Shenzhen, Guangdong 518172, P.R. China.
  • Department of Endocrinology, Key Laboratory of Endocrinology of National Health Commission, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 157 Malianwa Nor…

ORCID-Profile: Hsi-Yuan Huang, Hsien-Da Huang

Förderung

  • Guangdong Young Scholar Development Fund of Shenzhen Ganghong Group Co., Ltd.
  • Shenzhen-Hong Kong Cooperation Zone for Technology and Innovation
  • Warshel Institute for Computational Biology funding from Shenzhen City and Longgang District
  • Guangdong S&T programme
  • Shenzhen Science and Technology Innovation Program

Zitieren

APA

Wan, J., Jia, C., Dong, D., Chen, Y., Lin, Y. C., He, Y., Huang, H. Y., & Huang, H. D. (2025). DeepADR: multimodal prediction of adverse drug reaction frequency by integrating early-stage drug discovery information via Kolmogorov–Arnold networks. Briefings in Bioinformatics. https://doi.org/10.1093/bib/bbaf695

Vancouver

Wan J, Jia C, Dong D, Chen Y, Lin YC, He Y, et al. DeepADR: multimodal prediction of adverse drug reaction frequency by integrating early-stage drug discovery information via Kolmogorov–Arnold networks. Briefings in Bioinformatics. 2025. doi:10.1093/bib/bbaf695

BibTeX
@article{Wan2025,
  author = {Wan, Jingting and Jia, Chenyang and Dong, Danhong and Chen, Yigang and Lin, Yang-Chi-Dung and He, Yisheng and Huang, Hsi-Yuan and Huang, Hsien-Da},
  title = {DeepADR: multimodal prediction of adverse drug reaction frequency by integrating early-stage drug discovery information via Kolmogorov–Arnold networks},
  journal = {Briefings in Bioinformatics},
  year = {2025},
  doi = {10.1093/bib/bbaf695}
}
Kostenlos starten →